Company / Net Income
Illumina, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$850.0M
FY2025
5-year range
-$1.2B / $850.0M
FY2021-FY2025
Trend
+169.5%
vs FY2024
Sector context
#29 of 164
Health Care
What the data says
Illumina, Inc.'s net income of $850M is higher than 82% of companies in the Health Care sector (FY2025). Net Income returned to growth in FY2025 after 3 years of decline, reaching $850M.
Based on SEC 10-K filings.
$850M in FY2025 with a 5-year CAGR of +5.3%. Top quartile in the Health Care sector.
Improved from -$1.2B to $850M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +9.0%
- 5-Year CAGR
- +5.3%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 164This company $850.0M Sector average $467.5M
▼
+81.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +5.3%, indicating consistent growth.
- In FY2025, net income increased 169.5% year-over-year.
- Ranks #29 out of 164 companies in the Health Care sector.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $850.0M | +169.5% |
| FY2024 | -$1.2B | -5.3% |
| FY2023 | -$1.2B | -277.0% |
| FY2022 | $656.0M | -13.9% |
| FY2021 | $762.0M | +16.2% |
| FY2020 | $656.0M | -9.6% |
| FY2019 | $726.0M | +56.8% |
| FY2018 | $463.0M | +0.2% |
| FY2017 | $462.0M | -0.2% |
| FY2016 | $463.0M | +0.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026